<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Iran Red Crescent Med J</journal-id><journal-id journal-id-type="iso-abbrev">Iran Red Crescent Med J</journal-id><journal-id journal-id-type="doi">10.5812/ircmj</journal-id><journal-id journal-id-type="publisher-id">Kowsar</journal-id><journal-title-group><journal-title>Iranian Red Crescent Medical Journal</journal-title></journal-title-group><issn pub-type="ppub">2074-1804</issn><issn pub-type="epub">2074-1812</issn><publisher><publisher-name>Kowsar</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23682322</article-id><article-id pub-id-type="pmc">3652497</article-id><article-id pub-id-type="doi">10.5812/ircmj.5138</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>The Role of Vitamin C in Prevention of Preterm Premature Rupture of Membranes</article-title><alt-title alt-title-type="short">Vitamin C and Preterm Premature Rupture of Membranes</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ghomian</surname><given-names>Nayereh</given-names></name><xref ref-type="aff" rid="aff10584">1</xref></contrib><contrib contrib-type="author"><name><surname>Hafizi</surname><given-names>Leili</given-names></name><xref ref-type="aff" rid="aff10584">1</xref><xref ref-type="corresp" rid="cor10585">*</xref></contrib><contrib contrib-type="author"><name><surname>Takhti</surname><given-names>Zahra</given-names></name><xref ref-type="aff" rid="aff10584">1</xref></contrib></contrib-group><aff id="aff10584"><label>1</label>Department of Obstetrics and Gynecology, Imam Reza Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran</aff><author-notes><corresp id="cor10585"><label>*</label>Corresponding author: Leili Hafizi, Department of Obstetrics and Gynecology, Women's Health Research Center, Imam Reza Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran. Tel: +98-5118022608, Fax: +98-5118525305, E-mail: <email>hafizil@mums.ac.ir</email>.</corresp></author-notes><pub-date pub-type="epub"><day>05</day><month>2</month><year>2013</year></pub-date><pub-date pub-type="ppub"><month>2</month><year>2013</year></pub-date><volume>15</volume><issue>2</issue><fpage>113</fpage><lpage>116</lpage><history><date date-type="received"><day>11</day><month>4</month><year>2012</year></date><date date-type="rev-recd"><day>12</day><month>7</month><year>2012</year></date><date date-type="accepted"><day>08</day><month>1</month><year>2013</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2013, Iranian Red Crescent Medical Journal</copyright-statement><copyright-year>2013</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Background</title><p>Preterm premature rupture of membranes (PPROM) is one of the most important complications of the pregnancy and cause perinatal morbidity and mortality. History of PPROM is a risk factor of recurrent PPROM. Vitamin C plays an important role in collagen metabolism and increases resistance maintenance of the chorioamniotic membranes.</p></sec><sec><title>Objectives</title><p>The aim of this study is to evaluate the role of vitamin C supplementation in prevention of PPROM in women with a positive history of PPROM.</p></sec><sec><title>Patients and Methods</title><p>This clinical trial study was performed on 170 pregnant women with the history of PPROM, with singleton pregnancy and gestational age 14 weeks in Imam-Reza Hospital, Mashhad University of Medical Sciences during 2008 to 2010. They were randomly divided into two groups. The case patients received 100 mg vitamin C daily from 14th weeks of gestation. PPROM occurrence was compared between two groups as an indicator of the protective effect of vitamin C supplements.</p></sec><sec><title>Results</title><p>PPROM occurred in 44.7% of controls and 31.8% of cases (P &#x00026;lt; 0.05). PROM occurred in 34.1% of controls and 18.8% of cases (P &#x00026;lt; 0.05). Pregnancy was terminated at term gestation in 21.2% of controls and 49.4% of cases (P &#x00026;lt; 0.05). Rupture of membranes was significantly decreased in the case group.</p></sec><sec><title>Conclusions</title><p>Vitamin C supplementations after 14th weeks of gestation can prevent from PPROM in women with the history of PPROM.</p></sec></abstract><kwd-group kwd-group-type="author"><kwd>Ascorbic Acid</kwd><kwd>Pregnancy</kwd><kwd>Fetal Membranes, Premature Rupture</kwd><kwd>Prevention and Control</kwd></kwd-group></article-meta></front><body><sec id="sec6022"><title>1. Background</title><p>Premature rupture of membranes (<xref ref-type="bibr" rid="A5138R1">1</xref>) defined as leakage of amniotic fluid through rupturedchorioamnioticmembranes that occur before starting the labor pain at any gestational age. It is one of the most common problems in obstetrics and affects 10-20% of all pregnancies. (<xref ref-type="bibr" rid="A5138R2">2</xref>,<xref ref-type="bibr" rid="A5138R3">3</xref>) If PROMoccurrbefore term pregnancy (37 gestational weeks), it is named as preterm premature rupture of membranes (PPROM). Although PPROM involves 3% of pregnancies, it is the cause of one third of all preterm births with increased rates of neonatal and maternal morbidity and mortality (<xref ref-type="bibr" rid="A5138R4">4</xref>). Its pathophysiologic mechanism is little known. It has been reported that premature ruptured membranes have less collagen content, which is necessary to provide mechanical strength to fetal membranes and therefore tension resistance is decreased (<xref ref-type="bibr" rid="A5138R5">5</xref>). However, PPROM should be considered important because of intrauterine infection risk (<xref ref-type="bibr" rid="A5138R6">6</xref>). Smoking, previous PPROM, intrauterine infection, bacterialvaginosis,multifetalgestations, cervical shortening,hydramniosis, and inadequate availability of some nutrients during pregnancy such as copper, zinc, magnesium, &#x003b2;-carotenes, vitamin E, and vitamin C have been identified as risk factors for PPROM and low birth-weight (<xref ref-type="bibr" rid="A5138R7">7-9</xref>). Vitamin C is involved in collagen synthesis, collagen secretion, andcollagenolysisprocesses (<xref ref-type="bibr" rid="A5138R10">10</xref>). Occurrence of PPROM has been associated with changed patterns of collagen synthesis and decreased concentration of vitamin C at 28th weeks of gestation (<xref ref-type="bibr" rid="A5138R11">11</xref>). It is reported that PROM could be used as a functional test of vitamin C status during pregnancy (<xref ref-type="bibr" rid="A5138R12">12</xref>). Some studies have shown that there were lower levels of ascorbic acid (vitamin C) in serum, leucocytes, and amniotic fluid of cases with PPROM as compared to the control group (<xref ref-type="bibr" rid="A5138R13">13</xref>). But they have provided little information about the relationship between vitamin C intake and its role in PPROM. The aim of this study is to evaluate the role of vitamin C in prevention of PPROM.</p></sec><sec id="sec6023"><title>2. Objectives</title><p>The aim of this study is to evaluate the role of vitamin C supplementation in prevention of PPROM in women with a positive history of PPROM.</p></sec><sec id="sec6024"><title>3. Patients and Methods</title><p>One hundred and seventy pregnant women with 14 weeks gestational age and the history of at least one PPROM with singleton pregnancy were enrolled in this clinical trial, after being completely explained about study conditions and signing informed consent. The study was approved by the Ethics Committee of Mashhad University of Medical sciences, and was performed in Imam-Reza University Hospital during a time period of 2008 to 2010. Inclusion criteria was the history of at least one PPROM in previous pregnancies, body mass index (BMI) of 18.5-30 kg/m2, singleton pregnancy, normal fetus and normal amniotic fluid insonography, mother age of 18-35yrs, normal cervix length (more than 25mm), no Tobacco usage, and no consumption of vitamin C supplements. Patients were randomly divided into two groups:</p><p>For 85 women in the case group, 400&#x000b5;g folic acid daily was prescribed in the first trimester, then iron tablet containing 30 mg elemental iron and chewing tablet of 100 mg vitamin C (Iran-Darufactory) daily were added from 14th weeks of gestation (<xref ref-type="bibr" rid="A5138R2">2</xref>) and was continued up to 37th weeks.</p><p>In control group,85patientsweretreated similar except for chewing tablet of placebo insist of same shape of vitamin C tablets. A questionnaire was completed for each woman including age, weight, history of previous disease, history of previous pregnancies, and gestational age of PPROM at previous pregnancy. The patients were evaluated for bacterialvaginosisin the first visit, moreover anytime during the survey whenever the patient has been complaining ofvaginosissigns, and if discovered it was treated medially.Sonographywas performed for all of the cases during 12-14 weeks to evaluate the length of cervix and number of fetuses. All of thepatients were evaluated monthly during the second trimester. At the end of second trimester, they were evaluated withsonographyfor the volume of amniotic fluid and fetal anomalies. The fetal membrane rupture was obtained by sterile speculum and observing amniotic fluid existing from the cervix, fern test orNitrazintest. After delivery, the questionnaire was completed by data such as the date and cause of referring to the hospital, date and time of rupture of membranes, gestational age, neonate&#x02019;s sex, birth-weight, and five minute Apgar score. Data was analyzed by SPSS software (version 11). For quantitative variables, T test, and variance analysis were used if the variables were parametric inKolmograv-Smironovtest. Otherwise, Mann-Whitney and Cross-Calvaistests were used. Chi-square test was used for qualitative variables. P &#x02264; 0.05 wasconsidered statistically significant.</p></sec><sec id="sec6025"><title>4. Results</title><p>There was no significant difference between case and control groups in basic interventional factors (<xref ref-type="table" rid="tbl2298">Table 1</xref>). Rupture of membranes was significantly decreased in the case group in the shape of PPROM, PROM and during term labor. Mean latency period was significantly (P = 0.002) higher in case group (19.02 &#x000b1; 6.1 hours) vs. control group (13.42 &#x000b1; 6.3 hours). Both groups were statistically different in the view of gestational age, birth-weight, and neonatal Apgar score (<xref ref-type="table" rid="tbl2297">Table 2</xref>). In the case group, 61 patients (71.8%) had vaginal delivery and 24 patients (28.2%) underwent cesarean section. it was similar in the control group, (60 women (70.6%) underwent vaginal delivery and 25 women (29.4%) cesarean section). (P = 1.007). In the next step we compared neonatal outcomes between case and control groups in specific patient who were involved PPROM or PROM. The mean birth-weight of women with PROM was significantly higher in the case group (3068 gram) compared to the control (2968 gram) (P = 0.002). The mean neonatal Apgar score in patients with PROM was 9.0 in the case group and 8.3in the control group (P = 0.03). The mean gestational age at delivery was 38.1 weeks in case group and 37.7 weeks in control group (P = 0.02). Mean of latency period was 3.6 &#x000b1; 2.9 hours in case group and 3.3 &#x000b1; 3.6 hours in control group (P &#x02264; 0.001). The mean birth-weight of women with PPROM was 2370 grams in case and 2102 grams in control group (P &#x02264; 0.001). The mean neonatal Apgar score was 8 in patients with PPROM in case group and 7.3 in control group (P &#x02264; 0.001). The mean of latency period was 59.2 &#x000b1; 38.1 hours in case group and 27.5 &#x000b1; 14.6 hours in control group. (P &#x02264; 0.001) The mean gestational age at the time of delivery was 34.7 &#x000b1; 1.2 weeks in case group and 33.3 &#x000b1; 1.4 weeks in control group (P &#x02264; 0.001). All the mentioned differences were statistically significant.</p><table-wrap id="tbl2298" orientation="portrait" position="float"><label>Table 1.</label><caption><title>Comparison of Interventional Factors Between Case and Control Groups Interventional</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Interventional Factors, Mean</th><th align="left" rowspan="1" colspan="1">Case Group</th><th align="left" rowspan="1" colspan="1">Control Group</th><th align="left" rowspan="1" colspan="1">P value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><bold>Age, y</bold></td><td rowspan="1" colspan="1">29.8</td><td rowspan="1" colspan="1">29</td><td rowspan="1" colspan="1">0.132</td></tr><tr><td rowspan="1" colspan="1"><bold>Number of Pregnancy</bold></td><td rowspan="1" colspan="1">2.5</td><td rowspan="1" colspan="1">2.6</td><td rowspan="1" colspan="1">0.99</td></tr><tr><td rowspan="1" colspan="1"><bold>BMI, Kg/ m<sup>2</sup></bold></td><td rowspan="1" colspan="1">21.4</td><td rowspan="1" colspan="1">20.8</td><td rowspan="1" colspan="1">0.4</td></tr><tr><td rowspan="1" colspan="1"><bold>Gestational age at PPROM in previous pregnancy</bold></td><td rowspan="1" colspan="1">31.05</td><td rowspan="1" colspan="1">31.4</td><td rowspan="1" colspan="1">1.70</td></tr><tr><td rowspan="1" colspan="1"><bold>Number of Dead neonates</bold></td><td rowspan="1" colspan="1">0.3</td><td rowspan="1" colspan="1">0.6</td><td rowspan="1" colspan="1">1.88</td></tr><tr><td rowspan="1" colspan="1"><bold>Number of Abortion</bold></td><td rowspan="1" colspan="1">0.14</td><td rowspan="1" colspan="1">0.05</td><td rowspan="1" colspan="1">0.62</td></tr></tbody></table></table-wrap><table-wrap id="tbl2297" orientation="portrait" position="float"><label>Table 2.</label><caption><title>Comparison of Pregnancy and Neonatal OutcomesBetween Case and Control Groups</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Outcome</th><th align="left" rowspan="1" colspan="1">Case Group</th><th align="left" rowspan="1" colspan="1">Control Group</th><th align="left" rowspan="1" colspan="1">P value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><bold>Pregnancy, No. (%)</bold></td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">PPROM</td><td rowspan="1" colspan="1">27 (31.8)</td><td rowspan="1" colspan="1">38 (44.7)</td><td rowspan="1" colspan="1">0.000</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">PROM</td><td rowspan="1" colspan="1">16 (18.8)</td><td rowspan="1" colspan="1">29 (34.1)</td><td rowspan="1" colspan="1">0.000</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Normal <xref ref-type="table-fn" rid="fn1306">a</xref>
</td><td rowspan="1" colspan="1">42 (49.4)</td><td rowspan="1" colspan="1">18 (21.2)</td><td rowspan="1" colspan="1">0.000</td></tr><tr><td rowspan="1" colspan="1">
<bold>Neonatal, Mean &#x000b1; SD</bold>
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Mean gestational age at delivery (week)</td><td rowspan="1" colspan="1">37.1 &#x000b1; 1.9</td><td rowspan="1" colspan="1">35.9 &#x000b1; 2.8</td><td rowspan="1" colspan="1">0.000</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Mean birth weight, gram</td><td rowspan="1" colspan="1">2840 &#x000b1; 382</td><td rowspan="1" colspan="1">2630 &#x000b1; 529</td><td rowspan="1" colspan="1">0.000</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Neonatal Apgar score</td><td rowspan="1" colspan="1">8.4 &#x000b1; 0.7</td><td rowspan="1" colspan="1">7.83 &#x000b1; 0.7</td><td rowspan="1" colspan="1">0.000</td></tr></tbody></table><table-wrap-foot><fn id="fn1306"><p><sup>a</sup>Rupture of membrane during term delivery</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec6026"><title>5. Discussion</title><p>PPROM has been known as the main cause of preterm delivery and associated with increased rates of neonatal and maternal morbidity and mortality (<xref ref-type="bibr" rid="A5138R14">14-16</xref>).Although it has different causes, collagen metabolism is considered as the main factor in premature rupture of membranes. Vitamin C usage during pregnancy can modulate the collagen metabolism and cause the strength ofamniochorionmembranes. There are many factors that affect the availability of vitamin C during pregnancy.15Simhanet al. reported decreased level of vitamin C in women with premature rupture of membranes (<xref ref-type="bibr" rid="A5138R17">17</xref>). The results of this study showed that vitamin C usage incase group significantly increased the gestational age at delivery, neonatal Apgar score, birth-weight, and latency period. This finding was confirmed by the study ofBarretet al. He concluded that the administration of 100mg of vitamin C in pregnant women after 20th weeks of gestation can significantly decrease the incidence of PROM and PPROM (<xref ref-type="bibr" rid="A5138R1">18</xref>). Siegaet al. showed that the rates of membranes rupture before 37 weeks is increased with decrease of vitaminC supplements, although the relation was not statistically significant (<xref ref-type="bibr" rid="A5138R1">1</xref>). In addition, Hajifoghahaet al. reported that the usage of vitamin C supplements after 20th weeks of gestation prevents of PPROM (<xref ref-type="bibr" rid="A5138R19">19</xref>). Vermilion et al. performed a study that one group of pregnant women with the history of PPROM received vitamin C along with ferrous sulfate. Although the incidence of iron shortage anemia was decreased, no difference was observed in term of PPROM between case and control group (<xref ref-type="bibr" rid="A5138R20">20</xref>). Also, Casaneuvaet al. reported no significant difference between two groups in the view of vitamin C intake and PPROM (<xref ref-type="bibr" rid="A5138R21">21</xref>). These different results from the results of the present study may be due to the lower volume sample in their study. In Borna et al. study no statistically significant difference was reported between vitamin C supplements and placebo groups in terms of sepsis incidence, but resemble to our study, neonatal Apgar score and birth-weight was different between two groups (<xref ref-type="bibr" rid="A5138R22">22</xref>). Vitamin C is an essential nutrient, involved in several biochemical functions. It is an antioxidant that blocks the damaging effects of oxidative stress in vitro (<xref ref-type="bibr" rid="A5138R23">23</xref>). Therefore, vitamin C can prevent premature rupture of membranes through its role as an antioxidant or in collagen synthesis and maintenance (<xref ref-type="bibr" rid="A5138R24">24</xref>,<xref ref-type="bibr" rid="A5138R25">25</xref>). The present study had some limitations, we aimed to study the independent effect of vitamin C, but because the serum level of vitamin C was not assayed, isolation of the effect of a single nutrient is difficult. We propose a relationship between low vitamin C intake and an increased risk of preterm premature rupture of membranes. Vitamin C supplement is recommended to beadministered for pregnant women with the history of PPROM during pregnancy to prevent PPROM. Nevertheless, further studies with larger sample size and fewer limitations are needed to best clarify the role of vitamin C in prevention of PPROM especially in women with other risk factors of PPROM.</p></sec></body><back><ack><p>None declared.</p></ack><fn-group><fn id="afn4599" fn-type="other"><p><bold>Implication for health policy/practice/research/medical education:</bold> Premature rupture of membranes defined as amniotic fluid leakage before starting the labor pain. If PROM occurred before term pregnancy it is named as preterm premature rupture of membranes (PPROM). PPROM is associated with neonatal and maternal morbidity and mortality. It has been reported that premature ruptured membranes have less collagen content. Vitamin C is involved in collagen synthesis, secretion, and collagenolysis processes. Some studies have shown that there were lower levels of vitamin C in serum and amniotic fluid of cases with PPROM. The aim of this study is to evaluate the role of vitamin C in prevention of PPROM.</p></fn><fn id="afn4600" fn-type="other"><p><bold>Please cite this paper as:</bold> Hafizi Lotfabadi L. The Role of Vitamin C in Prevention of Preterm Premature Rupture of Membranes. Iran Red Cres Med J.2013;15(2):113-6. DOI: 10.5812/ircmj.5138</p></fn><fn id="afn4602" fn-type="financial-disclosure"><p><bold>Financial Disclosure:</bold> None declared.</p></fn><fn id="afn4603" fn-type="other"><p><bold>Funding Support:</bold> None declared.</p></fn></fn-group><ref-list><title>References</title><ref id="A5138R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siega-Riz</surname><given-names>Anna Maria</given-names></name><name><surname>Promislow</surname><given-names>Joanne HE</given-names></name><name><surname>Savitz</surname><given-names>David A</given-names></name><name><surname>Thorp</surname><given-names>John M</given-names></name><name><surname>McDonald</surname><given-names>Thad</given-names></name></person-group><article-title>Vitamin C intake and the risk of preterm delivery.</article-title><source>American journal of obstetrics and gynecology.</source><year>2003</year><volume>189</volume><issue>2</issue><fpage>519</fpage><lpage>525</lpage><pub-id pub-id-type="pmid">14520228</pub-id></element-citation></ref><ref id="A5138R2"><label>2</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cunningham</surname><given-names>FG</given-names></name><name><surname>Leveno</surname><given-names>KJ</given-names></name><name><surname>Bloom</surname><given-names>SL</given-names></name><name><surname>Hauth</surname><given-names>JC</given-names></name><name><surname>Rouse</surname><given-names>DJ</given-names></name><name><surname>Spong</surname><given-names>CY</given-names></name></person-group><source>Management of preterm labor. Williams obstetrics.</source><year>2010</year><edition>23th ed</edition><fpage>232</fpage><lpage>47</lpage><publisher-loc>New york</publisher-loc><publisher-name>MC Graw Hill</publisher-name></element-citation></ref><ref id="A5138R3"><label>3</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Mercer</surname><given-names>BM</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Petraglia</surname><given-names>F</given-names></name><name><surname>StrauSS</surname><given-names>GF</given-names></name><name><surname>Gabbe</surname><given-names>SG</given-names></name><name><surname>Wises</surname><given-names>G</given-names></name></person-group><source>Complicated Pregnancy.</source><year>2007</year><edition>4th ed</edition><fpage>713</fpage><lpage>27</lpage><chapter-title>Premature rupture of the membrane.</chapter-title><publisher-loc>London</publisher-loc><publisher-name>Informa health care</publisher-name></element-citation></ref><ref id="A5138R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parry</surname><given-names>S</given-names></name><name><surname>Strauss</surname><given-names>JF, 3rd</given-names></name></person-group><article-title>Premature rupture of the fetal membranes.</article-title><source>N Engl J Med.</source><year>1998</year><volume>338</volume><issue>10</issue><fpage>663</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1056/NEJM199803053381006</pub-id><pub-id pub-id-type="pmid">9486996</pub-id></element-citation></ref><ref id="A5138R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malak</surname><given-names>TM</given-names></name><name><surname>Ockleford</surname><given-names>CD</given-names></name><name><surname>Bell</surname><given-names>SC</given-names></name><name><surname>Dalgleish</surname><given-names>R</given-names></name><name><surname>Bright</surname><given-names>N</given-names></name><name><surname>Macvicar</surname><given-names>J</given-names></name></person-group><article-title>Confocal immunofluorescence localization of collagen types I, III, IV, V and VI and their ultrastructural organization in term human fetal membranes.</article-title><source>Placenta.</source><year>1993</year><volume>14</volume><issue>4</issue><fpage>385</fpage><lpage>406</lpage><pub-id pub-id-type="pmid">8248033</pub-id></element-citation></ref><ref id="A5138R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pasquier</surname><given-names>JC</given-names></name><name><surname>Picaud</surname><given-names>JC</given-names></name><name><surname>Rabilloud</surname><given-names>M</given-names></name><name><surname>Claris</surname><given-names>O</given-names></name><name><surname>Ecochard</surname><given-names>R</given-names></name><name><surname>Moret</surname><given-names>S</given-names></name><etal>et al.</etal></person-group><article-title>Neonatal outcomes after elective delivery management of preterm premature rupture of the membranes before 34 weeks' gestation (DOMINOS study).</article-title><source>Eur J Obstet Gynecol Reprod Biol.</source><year>2009</year><volume>143</volume><issue>1</issue><fpage>18</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1016/j.ejogrb.2008.10.017</pub-id><pub-id pub-id-type="pmid">19167805</pub-id></element-citation></ref><ref id="A5138R7"><label>7</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Institute of Medicine Food and Nutrition Board.</collab></person-group><source>Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids.</source><year>2000</year><publisher-loc>Washington DC</publisher-loc><publisher-name>National Academy Press</publisher-name></element-citation></ref><ref id="A5138R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khadem</surname><given-names>N</given-names></name><name><surname>Mohammadzadeh</surname><given-names>A</given-names></name><name><surname>Farhat</surname><given-names>AS</given-names></name><name><surname>Valaee</surname><given-names>L</given-names></name><name><surname>Khajedaluee</surname><given-names>M</given-names></name><name><surname>Parizadeh</surname><given-names>SM</given-names></name></person-group><article-title>Relationship between Low Birth Weight Neonate and Maternal Serum Zinc Concentration.</article-title><source>Iran Red Crescent Med J.</source><year>2012</year><volume>14</volume><issue>4</issue><fpage>240</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">22754688</pub-id></element-citation></ref><ref id="A5138R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tejero</surname><given-names>E</given-names></name><name><surname>Perichart</surname><given-names>O</given-names></name><name><surname>Pfeffer</surname><given-names>F</given-names></name><name><surname>Casanueva</surname><given-names>E</given-names></name><name><surname>Vadillo-Ortega</surname><given-names>F</given-names></name></person-group><article-title>Collagen synthesis during pregnancy, vitamin C availability, and risk of premature rupture of fetal membranes.</article-title><source>Int J Gynaecol Obstet.</source><year>2003</year><volume>81</volume><issue>1</issue><fpage>29</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">12676390</pub-id></element-citation></ref><ref id="A5138R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfeffer</surname><given-names>F</given-names></name><name><surname>Casanueva</surname><given-names>E</given-names></name><name><surname>Kamar</surname><given-names>J</given-names></name><name><surname>Guerra</surname><given-names>A</given-names></name><name><surname>Perichart</surname><given-names>O</given-names></name><name><surname>Vadillo-Ortega</surname><given-names>F</given-names></name></person-group><article-title>Modulation of 72-kilodalton type IV collagenase (Matrix metalloproteinase-2) by ascorbic acid in cultured human amnion-derived cells.</article-title><source>Biol Reprod.</source><year>1998</year><volume>59</volume><issue>2</issue><fpage>326</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9687303</pub-id></element-citation></ref><ref id="A5138R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bryant-Greenwood</surname><given-names>GD</given-names></name></person-group><article-title>The extracellular matrix of the human fetal membranes: Structure and function.</article-title><source>Placenta.</source><year>1998</year><volume>19</volume><issue>1</issue><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">9481779</pub-id></element-citation></ref><ref id="A5138R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casanueva</surname><given-names>E</given-names></name><name><surname>Ripoll</surname><given-names>C</given-names></name><name><surname>Tolentino</surname><given-names>M</given-names></name><name><surname>Morales</surname><given-names>RM</given-names></name><name><surname>Pfeffer</surname><given-names>F</given-names></name><name><surname>Vilchis</surname><given-names>P</given-names></name><etal>et al.</etal></person-group><article-title>Vitamin C supplementation to prevent premature rupture of the chorioamniotic membranes: a randomized trial.</article-title><source>Am J Clin Nutr.</source><year>2005</year><volume>81</volume><issue>4</issue><fpage>859</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">15817864</pub-id></element-citation></ref><ref id="A5138R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hadley</surname><given-names>CB</given-names></name><name><surname>Main</surname><given-names>DM</given-names></name><name><surname>Gabbe</surname><given-names>SG</given-names></name></person-group><article-title>Risk factors for preterm premature rupture of the fetal membranes.</article-title><source>Am J Perinatol.</source><year>1990</year><volume>7</volume><issue>4</issue><fpage>374</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1055/s-2007-999527</pub-id><pub-id pub-id-type="pmid">2222633</pub-id></element-citation></ref><ref id="A5138R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mercer</surname><given-names>BM</given-names></name><name><surname>Rabello</surname><given-names>YA</given-names></name><name><surname>Thurnau</surname><given-names>GR</given-names></name><name><surname>Miodovnik</surname><given-names>M</given-names></name><name><surname>Goldenberg</surname><given-names>RL</given-names></name><name><surname>Das</surname><given-names>AF</given-names></name><etal>et al.</etal></person-group><article-title>The NICHD-MFMU antibiotic treatment of preterm PROM study: impact of initial amniotic fluid volume on pregnancy outcome.</article-title><source>Am J Obstet Gynecol.</source><year>2006</year><volume>194</volume><issue>2</issue><fpage>438</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1016/j.ajog.2005.07.097</pub-id><pub-id pub-id-type="pmid">16458643</pub-id></element-citation></ref><ref id="A5138R15"><label>15</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>RJ</given-names></name><name><surname>Fanaroff</surname><given-names>AA</given-names></name><name><surname>Walsh</surname><given-names>ME</given-names></name></person-group><source>Fanaroff and Martins neonatal perinatal medicine.</source><year>2006</year><edition>8th ed</edition><fpage>1097</fpage><publisher-loc>Philadelphia</publisher-loc><publisher-name>Frank Polizzano</publisher-name></element-citation></ref><ref id="A5138R16"><label>16</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Petralia</surname><given-names>GF</given-names></name><name><surname>Strauss</surname><given-names>GF</given-names></name><name><surname>Gabbe</surname><given-names>SG</given-names></name><name><surname>Wises</surname><given-names>G</given-names></name></person-group><source>Complicated pregnancy.</source><year>2007</year><edition>4th ed</edition><fpage>852</fpage><lpage>85</lpage><publisher-loc>London</publisher-loc><publisher-name>In forma heath care</publisher-name></element-citation></ref><ref id="A5138R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simhan</surname><given-names>HN</given-names></name><name><surname>Canavan</surname><given-names>TP</given-names></name></person-group><article-title>Preterm premature rupture of membranes: diagnosis, evaluation and management strategies.</article-title><source>BJOG.</source><year>2005</year><volume>112 Suppl 1</volume><fpage>32</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1111/j.1471-0528.2005.00582.x</pub-id><pub-id pub-id-type="pmid">15715592</pub-id></element-citation></ref><ref id="A5138R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>BM</given-names></name><name><surname>Sowell</surname><given-names>A</given-names></name><name><surname>Gunter</surname><given-names>E</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name></person-group><article-title>Potential role of ascorbic acid and beta-carotene in the prevention of preterm rupture of fetal membranes.</article-title><source>Int J Vitam Nutr Res.</source><year>1994</year><volume>64</volume><issue>3</issue><fpage>192</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">7814234</pub-id></element-citation></ref><ref id="A5138R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hajifoghaha</surname><given-names>M</given-names></name><name><surname>Keshavarz</surname><given-names>T</given-names></name></person-group><article-title>Vitamin C supplementation and PROM.</article-title><source>Iran J Obstet Gynecol Infertil.</source><year>2008</year><volume>11</volume><issue>2</issue><fpage>33</fpage><lpage>9</lpage></element-citation></ref><ref id="A5138R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vermillion</surname><given-names>ST</given-names></name><name><surname>Kooba</surname><given-names>AM</given-names></name><name><surname>Soper</surname><given-names>DE</given-names></name></person-group><article-title>Amniotic fluid index values after preterm premature rupture of the membranes and subsequent perinatal infection.</article-title><source>Am J Obstet Gynecol.</source><year>2000</year><volume>183</volume><issue>2</issue><fpage>271</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1067/mob.2000.107653</pub-id><pub-id pub-id-type="pmid">10942458</pub-id></element-citation></ref><ref id="A5138R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casanueva</surname><given-names>E</given-names></name><name><surname>Magana</surname><given-names>L</given-names></name><name><surname>Pfeffer</surname><given-names>F</given-names></name><name><surname>Baez</surname><given-names>A</given-names></name></person-group><article-title>Incidence of premature rupture of membranes in pregnant women with low leukocyte levels of vitamin C.</article-title><source>Eur J Clin Nutr.</source><year>1991</year><volume>45</volume><issue>8</issue><fpage>401</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">1761000</pub-id></element-citation></ref><ref id="A5138R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borna</surname><given-names>S</given-names></name><name><surname>Borna</surname><given-names>H</given-names></name><name><surname>Khazardoost</surname><given-names>S</given-names></name><name><surname>Hantoushzadeh</surname><given-names>S</given-names></name></person-group><article-title>'Perinatal outcome in preterm premature rupture of membranes with Amniotic fluid index &#x0003c; 5 (AFI &#x0003c; 5).</article-title><source>BMC Pregnancy Childbirth.</source><year>2004</year><volume>4</volume><issue>1</issue><fpage>15</fpage><pub-id pub-id-type="doi">10.1186/1471-2393-4-15</pub-id><pub-id pub-id-type="pmid">15291965</pub-id></element-citation></ref><ref id="A5138R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gopalani</surname><given-names>S</given-names></name><name><surname>Krohn</surname><given-names>M</given-names></name><name><surname>Meyn</surname><given-names>L</given-names></name><name><surname>Hitti</surname><given-names>J</given-names></name><name><surname>Crombleholme</surname><given-names>WR</given-names></name></person-group><article-title>Contemporary management of preterm premature rupture of membranes: determinants of latency and neonatal outcome.</article-title><source>Am J Perinatol.</source><year>2004</year><volume>21</volume><issue>4</issue><fpage>183</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1055/s-2004-828609</pub-id><pub-id pub-id-type="pmid">15168316</pub-id></element-citation></ref><ref id="A5138R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fortunato</surname><given-names>SJ</given-names></name><name><surname>Menon</surname><given-names>R</given-names></name></person-group><article-title>Distinct molecular events suggest different pathways for preterm labor and premature rupture of membranes.</article-title><source>Am J Obstet Gynecol.</source><year>2001</year><volume>184</volume><issue>7</issue><fpage>1399</fpage><lpage>405</lpage><pub-id pub-id-type="pmid">11408859</pub-id></element-citation></ref><ref id="A5138R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plessinger</surname><given-names>MA</given-names></name><name><surname>Woods</surname><given-names>JR, Jr</given-names></name><name><surname>Miller</surname><given-names>RK</given-names></name></person-group><article-title>Pretreatment of human amnion-chorion with vitamins C and E prevents hypochlorous acid-induced damage.</article-title><source>Am J Obstet Gynecol.</source><year>2000</year><volume>183</volume><issue>4</issue><fpage>979</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1067/mob.2000.106676</pub-id><pub-id pub-id-type="pmid">11035350</pub-id></element-citation></ref></ref-list></back></article>